Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Quality Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥9.12 Million is below net income of CN¥15.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Shenzhen Bioeasy Biotechnology Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Shenzhen Bioeasy Biotechnology Co. Ltd..
Annual Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year earnings quality comparison for Shenzhen Bioeasy Biotechnology Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.87x | CN¥66.87 Million | CN¥13.74 Million | ▲ +136.0% |
| 2024 | 2.06x | CN¥34.26 Million | CN¥16.62 Million | ▲ +11.7% |
| 2022 | 1.85x | CN¥152.55 Million | CN¥82.66 Million | ▲ +70.9% |
| 2021 | 1.08x | CN¥255.42 Million | CN¥236.47 Million | ▲ +10.8% |
| 2020 | 0.97x | CN¥63.79 Million | CN¥65.45 Million | ▲ +33.8% |
| 2019 | 0.73x | CN¥67.24 Million | CN¥92.29 Million | ▼ -7.0% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥73.91 Million | ▲ +30.4% |
| 2017 | 0.60x | CN¥23.60 Million | CN¥39.27 Million | ▼ -61.2% |
| 2016 | 1.55x | CN¥36.31 Million | CN¥23.42 Million | — |